Screening for HPV in Men Who Have Sex with Men Using HIV Prevention
Screening Anal HPV Colonization in Men Sex Men Using Pre-exposure Prophylaxis for HIV
This study is testing if screening for HPV in men who have sex with men who are taking HIV prevention medication can help identify the virus and improve their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Centre Hospitalier Universitaire de Besancon Academic / other |
| Locations | 1 site (Besancon) |
| Trial ID | NCT06296602 on ClinicalTrials.gov |
What this trial studies
This interventional study investigates the presence of HPV in men who have sex with men (MSM) who are undergoing Pre-exposure Prophylaxis (PrEP) for HIV. Participants will receive anal swabs for HPV genotyping and cytology during their PrEP consultations at Besançon University Hospital. The study will last for three months, during which results from the samples will be collected and analyzed. Additionally, a medical proctology consultation may be offered based on the screening results.
Who should consider this trial
Good fit: Ideal candidates for this study are men who have sex with men and are currently using Pre-exposure Prophylaxis for HIV.
Not a fit: Patients who are women, under 18, or have a history of HPV-related cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of HPV in MSM, potentially leading to better preventive strategies.
How similar studies have performed: While this specific approach may be novel, similar studies have shown the importance of screening for HPV in high-risk populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Men sex Men Using Pre-exposure Prophylaxis for HIV Follow up au CHU de Besançon. Exclusion Criteria: * Women * No MSM * Under 18 * History of HPV related cancer
Where this trial is running
Besancon
- CHU Besançon — Besancon, France (Recruiting)
Study contacts
- Study coordinator: Cedric LEBRETON, Dr
- Email: c1lebreton@chu-besancon.fr
- Phone: 03 81 21 88 98
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.